Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ASIC3 | Q9UHC3 | 2/20 | 0.59 |
| ▸ | MIF | P14174 | 1/20 | 0.59 |
| ▸ | KMO | O15229 | 3/20 | 0.53 |
| ▸ | RAB9A | P51151 | 4/20 | 0.52 |
| ▸ | NPC1 | O15118 | 3/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | RECQL | P46063 | 1/20 | 0.47 |
| ▸ | LDHA | P00338 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.43 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.43 |
| ▸ | KDR | P35968 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30412356 | 1.00 | ASIC3 (0.59) | ASIC3MIFKMORAB9ANPC1 | |
| SCHEMBL28265036 | 0.98 | ASIC3 (0.57) | ASIC3MIFKMORAB9ANPC1 | |
| SCHEMBL28334660 | 0.98 | ASIC3 (0.57) | ASIC3MIFKMORAB9ANPC1 | |
| SCHEMBL27908367 | 0.98 | ASIC3 (0.57) | ASIC3MIFKMORAB9ANPC1 | |
| SCHEMBL19009227 | 0.90 | MIF (0.48) | ASIC3MIFKMORAB9ANPC1 | |
| SCHEMBL284286 | 0.84 | ASIC3 (0.71) | ASIC3MIFKMORAB9ANPC1 | |
| SCHEMBL18850043 | 0.83 | FAAH (0.43) | ASIC3MIFRAB9ANPC1SMN1; SMN2 | |
| SCHEMBL28218682 | 0.81 | ASIC3 (0.68) | ASIC3MIFKMORAB9ANPC1 | |
| SCHEMBL29406194 | 0.81 | ASIC3 (0.68) | ASIC3MIFKMORAB9ANPC1 | |
| SCHEMBL27904874 | 0.81 | ASIC3 (0.68) | ASIC3MIFKMORAB9ANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 389 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250126962-A1 | Light-Emitting Element | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2025-04-17 | — | — | US | disclosed |
| US-20250063937-A1 | Light-Emitting Element | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2025-02-20 | — | — | US | disclosed |
| US-12150325-B2 | Light-emitting element | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2024-11-19 | — | — | US | disclosed |
| US-12100795-B2 | Light-emitting element | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2024-09-24 | — | — | US | disclosed |
| US-20240164124-A1 | Light-Emitting Element | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2024-05-16 | — | — | US | disclosed |
| WO-2023230179-A1 | COMPOSITIONS AND METHODS FOR DETECTING AND TREATING CANCER | CASE WESTERN RESERVE UNIVERSITY (US) | 2023-11-30 | — | — | WO | disclosed |
| US-20230363260-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-11-09 | — | — | US | disclosed |
| US-11812626-B2 | Light-emitting element | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2023-11-07 | — | — | US | disclosed |
| US-11812626-B2 | Light-emitting element | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2023-11-07 | — | — | US | disclosed |
| US-11812626-B2 | Light-emitting element | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2023-11-07 | — | — | US | disclosed |
| US-20090075936-A1 | Proteasome inhibitors and methods of using the same | CEPHALON, INC. (US) | 2009-03-19 | — | — | US | disclosed |
| US-7468383-B2 | Proteasome inhibitors and methods of using the same | CEPHALON, INC. (US) | 2008-12-23 | — | — | US | disclosed |
| EP-1956022-A1 | COMPOUND FOR ORGANIC ELECTROLUMINESCENT ELEMENT AND ORGANIC ELECTROLUMINESCENT ELEMENT | Nippon Steel Chemical Co., Ltd. (JP) | 2008-08-13 | — | — | EP | disclosed |
| WO-2008062044-A1 | 2-HYDROXY-1,3-DIAMINOPROPANE DERIVATIVES | NOVARTIS AG (CH) | 2008-05-29 | — | — | WO | disclosed |
| US-20070225296-A1 | Arylalkylamine Compound and Process for Preparing the Same | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2007-09-27 | — | — | US | disclosed |
| US-20070225296-A1 | Arylalkylamine Compound and Process for Preparing the Same | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2007-09-27 | — | — | US | disclosed |
| US-20070142350-A1 | THERAPEUTIC USES OF DERIVATIVES OF PIPERIDINYL- AND PIPERAZINYL-ALKYL CARBAMATES | SANOFI-AVENTIS (FR) | 2007-06-21 | — | — | US | disclosed |
| US-20070142350-A1 | THERAPEUTIC USES OF DERIVATIVES OF PIPERIDINYL- AND PIPERAZINYL-ALKYL CARBAMATES | SANOFI-AVENTIS (FR) | 2007-06-21 | — | — | US | disclosed |
| US-7214798-B2 | Derivatives of piperidinyl-and piperazinyl-alkyl carbamates, preparation methods thereof and application of same in therapeutics | SANOFI-AVENTIS (FR) | 2007-05-08 | — | — | US | disclosed |
| US-7214798-B2 | Derivatives of piperidinyl-and piperazinyl-alkyl carbamates, preparation methods thereof and application of same in therapeutics | SANOFI-AVENTIS (FR) | 2007-05-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12100795-B2 | Light-emitting element | HPRT1, NR2E3, LAGE3 | ASIC3 391/4885MIF 2124/4885KMO 4266/4885 |
| US-20250063937-A1 | Light-Emitting Element | HPRT1, APRT, LAGE3 | ASIC3 280/4885MIF 2202/4885KMO 4151/4885 |
| US-20070225296-A1 | Arylalkylamine Compound and Process for Preparing the Same | CASR, CNR1, CNR2 | ASIC3 252/4885MIF 4768/4885KMO 1222/4885 |
| US-20070142350-A1 | THERAPEUTIC USES OF DERIVATIVES OF PIPERIDINYL- AND PIPERAZINYL-ALKYL CARBAMATES | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, CBR3, H1-2 | ASIC3 195/4885MIF 4646/4885KMO 4095/4885 |
| US-20090075936-A1 | Proteasome inhibitors and methods of using the same | PSMB11, PSMB5, PSMB6 | ASIC3 4111/4885MIF 3964/4885KMO 3798/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.